NO972688D0 - Anvendelse av aminopurin-antivirale-midler for behandling og profylakse av latente herpesvirus-infeksjoner - Google Patents

Anvendelse av aminopurin-antivirale-midler for behandling og profylakse av latente herpesvirus-infeksjoner

Info

Publication number
NO972688D0
NO972688D0 NO972688A NO972688A NO972688D0 NO 972688 D0 NO972688 D0 NO 972688D0 NO 972688 A NO972688 A NO 972688A NO 972688 A NO972688 A NO 972688A NO 972688 D0 NO972688 D0 NO 972688D0
Authority
NO
Norway
Prior art keywords
prophylaxis
treatment
herpes virus
antiviral agents
virus infections
Prior art date
Application number
NO972688A
Other languages
English (en)
Other versions
NO313862B1 (no
NO972688L (no
Inventor
Hugh John Field
Alana Maureen Thackray
Teresa Helen Bacon
David Sutton
Richard Anthony Vere Hodge
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27451235&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO972688(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB9425012.3A external-priority patent/GB9425012D0/en
Priority claimed from GBGB9506663.5A external-priority patent/GB9506663D0/en
Priority claimed from GBGB9517308.4A external-priority patent/GB9517308D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of NO972688D0 publication Critical patent/NO972688D0/no
Publication of NO972688L publication Critical patent/NO972688L/no
Publication of NO313862B1 publication Critical patent/NO313862B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO19972688A 1994-12-12 1997-06-11 Anvendelse av aminopurin-antiviral midler for behandling og profylakse av latente herpesvirus-infeksjoner NO313862B1 (no)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GBGB9425012.3A GB9425012D0 (en) 1994-12-12 1994-12-12 Pharmaceuticals
GBGB9506663.5A GB9506663D0 (en) 1995-03-31 1995-03-31 Pharmaceuticals
GBGB9517308.4A GB9517308D0 (en) 1995-08-24 1995-08-24 Pharmaceuticals
US08/522,790 US5840763A (en) 1994-12-12 1995-09-01 Treatment of a latent infection of herpes viruses
PCT/EP1995/004692 WO1996018396A1 (en) 1994-12-12 1995-11-23 Use of aminopurine antiviral agents for the treatment and prophylaxis of latent herpesvirus infections

Publications (3)

Publication Number Publication Date
NO972688D0 true NO972688D0 (no) 1997-06-11
NO972688L NO972688L (no) 1997-08-07
NO313862B1 NO313862B1 (no) 2002-12-16

Family

ID=27451235

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19972688A NO313862B1 (no) 1994-12-12 1997-06-11 Anvendelse av aminopurin-antiviral midler for behandling og profylakse av latente herpesvirus-infeksjoner

Country Status (24)

Country Link
US (2) US5840763A (no)
EP (1) EP0799039B1 (no)
JP (1) JP2008088189A (no)
CN (1) CN1098687C (no)
AP (1) AP669A (no)
AT (1) ATE208198T1 (no)
AU (1) AU699627B2 (no)
BG (1) BG63815B1 (no)
BR (1) BR9509986A (no)
CA (1) CA2207503C (no)
CY (1) CY2339B1 (no)
CZ (1) CZ291545B6 (no)
DE (1) DE69523776T2 (no)
DK (1) DK0799039T3 (no)
ES (1) ES2166834T3 (no)
HK (1) HK1003259A1 (no)
HU (1) HU222835B1 (no)
NO (1) NO313862B1 (no)
NZ (1) NZ297424A (no)
PT (1) PT799039E (no)
RO (1) RO120042B1 (no)
SI (1) SI0799039T1 (no)
SK (1) SK282983B6 (no)
WO (1) WO1996018396A1 (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5840763A (en) * 1994-12-12 1998-11-24 Smithkline Beecham Plc Treatment of a latent infection of herpes viruses
US6047209A (en) * 1999-04-02 2000-04-04 Denny; Jeffrey Paul Method and apparatus for maintenance of pierced orifices
AU2006230269A1 (en) * 2005-03-30 2006-10-05 Novartis Ag Penciclovir or famciclovir for the treatment of recurrent genital herpes with a one-day application
CL2006000697A1 (es) * 2005-03-30 2008-05-09 Novartis Ag Uso de famciclovir para el tratamiento del herpes labial recurrente.
US20100136106A1 (en) * 2005-06-08 2010-06-03 Gary Liversidge Modified Release Famciclovir Compositions
EP3753563A1 (en) * 2019-06-20 2020-12-23 Helmholtz-Zentrum für Infektionsforschung GmbH Anti-herpesvirus guanosine analogue for the inhibition of basal autophagy

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4423050A (en) * 1981-05-21 1983-12-27 Syntex (U.S.A.) Inc. 9-(1,3-Dihydroxy-2-propoxymethyl)guanine as antiviral agent
US4355032B2 (en) * 1981-05-21 1990-10-30 9-(1,3-dihydroxy-2-propoxymethyl)guanine as antiviral agent
US4461757A (en) * 1983-02-23 1984-07-24 Ens Bio Logicals Inc. Dimethylaminomethylenated anti-herpes compounds
DE3485225D1 (de) * 1983-08-18 1991-12-05 Beecham Group Plc Antivirale guanin-derivate.
GB9015051D0 (en) * 1990-07-07 1990-08-29 Beecham Group Plc Pharmaceutical treatment
US5840763A (en) * 1994-12-12 1998-11-24 Smithkline Beecham Plc Treatment of a latent infection of herpes viruses

Also Published As

Publication number Publication date
US5840763A (en) 1998-11-24
HK1003259A1 (en) 1998-10-23
NO313862B1 (no) 2002-12-16
SK282983B6 (sk) 2003-01-09
CN1098687C (zh) 2003-01-15
DE69523776D1 (de) 2001-12-13
CY2339B1 (en) 2004-02-06
ES2166834T3 (es) 2002-05-01
SI0799039T1 (en) 2002-06-30
NO972688L (no) 1997-08-07
DE69523776T2 (de) 2002-08-01
HUT77437A (hu) 1998-04-28
EP0799039A1 (en) 1997-10-08
CZ291545B6 (cs) 2003-04-16
PT799039E (pt) 2002-04-29
BG63815B1 (bg) 2003-02-28
CN1175212A (zh) 1998-03-04
CA2207503A1 (en) 1996-06-20
SK75197A3 (en) 1997-11-05
CA2207503C (en) 2006-07-18
BG101608A (en) 1998-02-27
AU4257896A (en) 1996-07-03
BR9509986A (pt) 1997-11-25
US5916893A (en) 1999-06-29
RO120042B1 (ro) 2005-08-30
MX9704336A (es) 1997-09-30
AU699627B2 (en) 1998-12-10
HU222835B1 (hu) 2003-11-28
DK0799039T3 (da) 2002-01-28
WO1996018396A1 (en) 1996-06-20
ATE208198T1 (de) 2001-11-15
CZ179997A3 (en) 1997-09-17
AP9701001A0 (en) 1997-07-31
EP0799039B1 (en) 2001-11-07
JP2008088189A (ja) 2008-04-17
NZ297424A (en) 2000-07-28
AP669A (en) 1998-09-04

Similar Documents

Publication Publication Date Title
BR9406209A (pt) Derivados heterociclicos no tratamento de isquemia e doenças relacionadas
ZA939677B (en) Use of dideoxy nucleoside analogues in the treatment of viral infections
NO995622L (no) Karbocyklisk nukleosidhemisulfat og anvendelse derav for behandling av virale infeksjoner
NO940810D0 (no) Behandling av virusinfeksjoner
FI932847A0 (fi) HIV-proteasinhibitorer som aer anvaendbara foer behandling av aids
NO972688D0 (no) Anvendelse av aminopurin-antivirale-midler for behandling og profylakse av latente herpesvirus-infeksjoner
GR3023611T3 (en) Penciclovir and famciclovir and related guanine derivatives for the treatment of the hiv-1 infections
DE69028993D1 (de) Verwendung von kaffein bei der behandlung von herpes-simplex-virusinfektionen
NO983402L (no) Nukeosidanaloger i kombinasjonsterapi av herpes simplex infeksjoner
EP0382551A3 (en) Prevention and treatment of herpes virus infections
ZA926963B (en) Method of treating latent herpes viral infections.
GB9419692D0 (en) Treatment of herpes infections
BR9406575A (pt) Método de combater infecçoes virais de herpes simplex aciclovir-resistentes
EP0655919A4 (en) TREATMENT OF VIRAL INFECTIONS IN MAN.
BR0012380A (pt) 2-amino-benzoxazinonas para o tratamento de vìrus do herpes simples
ZA941471B (en) Treatment of viral infections
IL108749A0 (en) Selective treatment of enteroviral-caused infections in humans
GB9422923D0 (en) Treatment of viral infections
IT1298164B1 (it) Impiego di allantoina come unico principio attivo antivirale per il trattamento e la profilassi dell'herpes simplex

Legal Events

Date Code Title Description
MK1K Patent expired